RxDoctor Payments Data

Steven Burdine, MD

Family Medicine · Eden, NCNPI 1356563969

Payments from drug & device makers

$4,415in general payments, 2019–2025

Across 271 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$536
  • Boehringer Ingelheim$327
  • GSK$298
  • Amgen$296
  • Pfizer$279
  • AstraZeneca$242
  • plus $2K from 41 others

What the payments were for

  • Food & beverage$4,39299%
  • Education$231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,415 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$153,980
Medicare patients
342
Services billed
3,908

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AbrysvoRsv Vacc, Pref A And Pref B/Pf253$80,977
OzempicSemaglutide67$66,182
EliquisApixaban70$64,633
TrulicityDulaglutide45$58,534
FarxigaDapagliflozin Propanediol44$52,842
ShingrixVaricella-Zoster Ge/As01b/Pf202$44,764
XareltoRivaroxaban36$38,260
JardianceEmpagliflozin52$36,157
MounjaroTirzepatide30$32,722
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$29,848
TradjentaLinagliptin35$21,952
MyrbetriqMirabegron18$15,666
JanuviaSitagliptin Phosphate11$12,097
Boostrix TdapDiphth,pertuss(Acell),tet Vac113$7,706
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$6,774

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerAbrysvo, Eliquis, Premarin, Paxlovid$279$154,712371 claims
Lilly USA, LLCTrulicity, Mounjaro$536$91,25675 claims
GSKShingrix, Trelegy Ellipta, Breo Ellipta, Incruse Ellipta$298$85,473258 claims
Novo NordiskOzempic$225$66,18267 claims
Boehringer IngelheimJardiance, Tradjenta$327$58,10987 claims
AstraZenecaFarxiga$242$52,84244 claims
Johnson & JohnsonXarelto$23$38,26036 claims
Astellas Pharma US IncMyrbetriq$113$15,66618 claims
MerckJanuvia$160$12,09711 claims
AbbVieSynthroid$181$1,59044 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Eden

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →